4Yoshino T,Nisijima K,Shioda k,et al. Perospirone,a novel a- typical antipsychotic drug, potentiates fluoxetine-indueed in- creases in dopmnine levels via multireceptor actions in the rat medial prefrontal cortex[J]. Neuroscienee Letters, 2004, 364 (1):16-21.
5Masui T, Honma H, Kondo C, et al. Perospirone therapy in elderly patients with schizophrenia[J]. Seishin Shinkeigaku Zasshi, 2003,105 (10) : 1247-1253.
6Yasui-Furukori N, Furukori H, Nakagami T, et al. Steady-state pharrnaeokineties of a new antipsyehotic agent perospirnoe and its active metabolite, and its relationship with prolaetin re- sponse[J]. Ther Drug Monit,2004,26(4):361-365.
7Kitamura A, Mizuno Y,Natsui K,et al. Characterization of hu- man cytochrome P450 enzymes involved in the in vitro me- tabolismof perospirone[J]. Biopharm Drug Dispos, 2005, 26 (2):59-65.
8SHIMAKURA J, TANI N, MIZUNO Y, et al. In vitro drug- drug interactions with perospirone and concomitantly adminis- tered drugs in human liver mierosomcs[J]. Eur J Drug Metab Pharmacokinet, 2003,28 (1) : 67-72.
7Onrust SV, McClellan K. Perospirone [J]. CNS Drugs, 2001,15(4) :329-337.
8Moller HJ. Novel antipsychoties in the long-term treat ment of schizophrenia[J]. World J Biol Psychiatry, 2004, 5(1) :9- 19.
9Yoshino T,Nisijima K,Shioda K,et al.Perospirone,a novel atypical antipsychotic drug, potentiates fluoxetine-induced increases in dopamine levels via multireceptor actions in the rat medial prefrontal cortex [J]. Neurosci Lett, 2004,364 (1) : 16-21.
10Remington G,Kapur S. D2 and 5-HT2 receptor effects of antipsychotics: bridging basic and clinical findings using PET[J]. J Clin Psychiatry,1999,60 Suppl 10:S5- 19.
6Yoshino T, Nisijima K, Shioda K, et al. Perospirone, a novel atypical antipsychotic drug, potentiates fluoxetine-in- duced increases in dopamine levels via multireceptor actions in the rat medial prefrontal cortex[J]. Neurosci Lett, 2004, 364(1) :16.
7Littrell RA, Schneiderdan M. The neurobiology of schizophrenia [ J ]. Pharmacotherapy, 1996,16 (6 Pt 2 ) : 143 s-147 s.
8Risch SC. Pathophysiology of schizophrenia and the role of newer antipsychotlcs [ J ]. Pharmacotherapy, 1996,16 ( 1 Pt 2 ) : 11-4.
9Mizuno Y, Komuro S, Kanamaru H. Distribution of peros- pirone to melanin in pigmented rats E J ]- Eur J Drug Metabol Pharmaeokinet, 2003,28 ( 1 ) : 73 - 79.
10Masuia T,Kusumia I, Takahashi Y, et al. Efficacy of carbama- zepine against neuroleptic-induced akathisiain treatment with perospirone: case series [ J ]. Prog Neuropsychopharmacol Biol Psychiatry,2005,29(2) :343 - 346.
